Business

KORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026

MAHWAH, NJ, April 16, 2026--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report first quarter 2026 financial results on Wednesday, May 6, 2026. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the fi

articleKoru Medical Systems, Inc.April 16, 20262/company/repro-med-systems-inc/news/koru-medical-systems-to-report-first-quarter-2026-financial-results-on-may-6-2026
KORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026

About this update from Koru Medical Systems, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/2c4a5f5587b9bcaa01091d8cf81c59e3"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Gc3zrMkF0Ree7GHZfTJCxA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MA--/https://media.zenfs.com/en/business-wire.com/2c4a5f5587b9bcaa01091d8cf81c59e3","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/HviOja1Db6wZdjuPIs0.zQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0/https://media.zenfs.com/en/business-wire.com/2c4a5f5587b9bcaa01091d8cf81c59e3","width":1024,"height":512}},"lazy":false},{"type":"text","content":"MAHWAH, NJ, April 16, 2026--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report first quarter 2026 financial results on Wednesday, May 6, 2026. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.","length":584,"tagName":"p"},{"type":"text","content":"Conference Call and Webcast Details","length":35,"tagName":"p"},{"type":"text","content":"The conference call can be accessed by dialing (877)-407-0784 for participants in the U.S. or Canada and (201)-689-8560 for international callers. A live and archived webcast of the event can be accessed via the IR Calendar on the News/Events page of the Investors section of KORU Medical’s website at www.korumedical.com. The archived webcast will be available for six months.","length":377,"tagName":"p"},{"type":"text","content":"About KORU Medical Systems","length":26,"tagName":"p"},{"type":"text","content":"KORU Medical Systems develops, manufactures, and commercializes innovative and patient-centric large volume subcutaneous infusion solutions that improve quality of life for patients around the world. The Freedom Syringe Infusion System (the "Freedom System") currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Sa...

More updates from Koru Medical Systems, Inc.

KORU Medicalsubcutaneous infusionFreedom SystemKORU Medical Systems, Inc.KORU Medical Systemsmedical technology companyFreedom Syringe Infusion Systemarchived webcastambulatory infusion centerBUSINESS WIRE